Keywords: GlaxoSmithKline, Tropical diseases, Rare diseases, Malaria, Research, Sustainable pricing

GSK‘s “Open Innovation” strategy to help deliver medicines to people in the world's poorest countries

Article | 21 January 2010

UK drug giant GlaxoSmithKline’s chief executive, Andrew Witty, yesterday announced a series of new initiatives targeted at further transforming ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

GlaxoSmithKline

GSK

Drug Discovery

Go to company listing